Patents by Inventor Ko Fujimori

Ko Fujimori has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acid construct, metabolic disordered non-human animal and use thereof
    Patent number: 7586021
    Abstract: The present invention provides a transgenic non-human animal comprising a human-derived LXR? mutant gene to express a human LXR? mutant protein, wherein the human LXR? mutant is an isoform of LXR? involved in inhibition of normal cholesterol metabolism by normal LXR?; a nucleic acid construct which can be used to produce the transgenic non-human animal; and use thereof.
    Type: Grant
    Filed: May 11, 2006
    Date of Patent: September 8, 2009
    Assignee: Sumitomo Chemical Company, Limited
    Inventors: Ko Fujimori, Koichi Saito
  • Nucleic acid construct, metabolic disordered non-human animal and use thereof
    Publication number: 20060277617
    Abstract: The present invention provides a transgenic non-human animal comprising a human-derived LXR? mutant gene to express a human LXR? mutant protein, wherein the human LXR? mutant is an isoform of LXR? involved in inhibition of normal cholesterol metabolism by normal LXR?; a nucleic acid construct which can be used to produce the transgenic non-human animal; and use thereof.
    Type: Application
    Filed: May 11, 2006
    Publication date: December 7, 2006
    Inventors: Ko Fujimori, Koichi Saito
  • Liver x receptor alpha splicing mutant protein, gene thereof and utilization of the same
    Publication number: 20060247421
    Abstract: The present invention provides a liver X receptor ? splicing mutant protein which is an isoform of a liver X receptor ?, and which comprises at least an amino acid sequence encoded by exon 5 of a liver X receptor ? gene, a gene thereof, and use thereof, and these can be utilized in development of methods and agents useful for preventing, diagnosing or treating diseases and abnormalities involved in inhibition of normal cholesterol metabolism by a normal liver X receptor ?.
    Type: Application
    Filed: May 13, 2004
    Publication date: November 2, 2006
    Inventors: Ko Fujimori, Koichi Saito